Current status of in vitro models for rare gynaecological cancer research

This publication has 88 references indexed in Scilit:

• APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway
  Archives of Biochemistry and Biophysics, 2024
• The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids
  Biomedicine & Pharmacotherapy, 2023
• Epidemiological trends and risk factors of gynecological cancers: an update
  Medical Oncology, 2023
• Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment
  Advanced Drug Delivery Reviews, 2022
• OI inhibits development of ovarian cancer by blocking crosstalk between cancer cells and macrophages via HIF-1α pathway
  Biochemical and Biophysical Research Communications, 2022
• Diagnosis and management of gestational trophoblastic disease: 2021 update
  International Journal of Gynecology & Obstetrics, 2021
• Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model
  Acta Biomaterialia, 2021
• Genetic instability of in vitro cell lines: Implications for genetic toxicity testing
  Environmental and Molecular Mutagenesis, 2019
• Major changes of cell function and toxicant sensitivity in cultured cells undergoing mild, quasi-natural genetic drift
  Archives of Toxicology, 2018
• Malignant ovarian germ-cell tumours
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2012